The negative effects of anticoagulants are well-known in patients with renal impairment, drug-drug interaction, lower physical conditions, and multiple comorbidities. We highlight that even in patients with controllable multiple risks for rivaroxaban use, add-on inevitable risks will lead to negative effects greater than those expected.
Keywords: drug–drug interaction; erythromycin; renal dysfunction; rivaroxaban.
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.